The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning

Trends in Cardiovascular Medicine

Volumn 15, Issue 2, 2005, Pages 69-75

  Hausenloy, Derek J ^a   Tsang, Andrew ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REPERFUSION INJURY SALVAGE KINASE; UNCLASSIFIED DRUG;

CONDITIONING; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INHIBITION KINETICS; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REPERFUSION INJURY; SHORT SURVEY;

EID: 18844458509     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.03.001     Document Type: Review

References (47)

1. L Argaud, J Gateau-Roesch, D Loufouat, and M Ovize Postconditioning inhibits mitochondrial permeability transition Circulation 18 2005 194 197
2. CP Baines, CX Song, and YT Zheng Protein kinase C-ε interacts with and inhibits the permeability transition pore in cardiac mitochondria Circ Res 92 2003 873 880
3. CP Baines, J Zhang, and GW Wang Mitochondrial PKCε and MAPK form signaling modules in the murine heart: Enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection Circ Res 90 2002 390 397
4. M Behrends, R Schulz, and H Post Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs Am J Physiol 279 2000 H1111 H1119
5. RM Bell, and DM Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515
6. RM Bell, and DM Yellon Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS J Mol Cell Cardiol 35 2003 185 193
7. E Braunwald, and RA Kloner Myocardial reperfusion: a double-edged sword? J Clin Invest 76 1985 1713 1719
8. PS Brookes, EP Salinas, and K Darley-Usmar Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release J Biol Chem 275 2000 20474 20479
9. S Davidson, DJ Hausenloy, and M Duchen Insulin inhibits opening of the mitochondrial permeability transition pore via the reperfusion injury salvage kinase (RISK) pathway Circulation 100 2004 131
10. F Fath-Ordoubadi, and K Beatt Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview or randomized placebo-controlled trials Circulation 96 1997 1152 1156
11. B Freude, TN Masters, and F Robicsek Apoptosis is initiated by myocardial ischemia and executed during reperfusion J Mol Cell Cardiol 32 2000 197 208
12. RM Fryer, PF Pratt, and AK Hsu Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection J Pharmacol Exp Ther 296 2001 642 649
13. Y Fujio, T Nguyen, and D Wencker Akt promotes survival of cardiomyocytes against ischemia-reperfusion injury in mouse heart Circulation 101 2000 660 667
14. RA Gottlieb, KO Burleson, and RA Kloner Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
15. ER Gross, AK Hsu, and GJ Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 2004 960 966
16. DJ Hausenloy, HL Maddock, and GF Baxter Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55 2002 534 543
17. DJ Hausenloy, and DM Yellon The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion J Mol Cell Cardiol 35 2003 339 341
18. DJ Hausenloy, and DM Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460
19. DJ Hausenloy, DM Yellon, and S Mani-Babu Preconditioning protects by inhibiting the mitochondrial permeability transition Am J Physiol 287 2004 H841 H849
20. DJ Hausenloy, A Tsang, and MM Mocanu Ischemic preconditioning protects by activating pro-survival kinases at reperfusion Am J Physiol 288 2005 H971 H976
21. G Heusch Postconditioning: old wine in a new bottle? J Am Coll Cardiol 44 2004 1111 1112
22. AK Jonassen, MN Sack, and OD Mjos Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling Circ Res 89 2001 1191 1198
23. M Juhaszova, DB Zorov, and SH Kim Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 2004 1535 1549
24. H Kin, MT Lofye, and BS Amerson Cardioprotection by " postconditioning" is mediated by increased retention of endogenous intravascular adenosine and activation of A2A receptors during reperfusion Circulation 100 2004 803
25. H Kin, ZQ Zhao, and HY Sun Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion Cardiovasc Res 62 2004 74 85
26. T Krieg, Q Qin, and EC McIntosh ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases Am J Physiol 283 2002 H2322 H2330
27. T Krieg, L Cui, and Q Qin Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF J Mol Cell Cardiol 36 2004 435 443
28. T Krieg, Q Qin, and S Philipp Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS Am J Physiol 287 2004 H2606 H2611
29. SR Mehta, S Yusuf, and R Diaz Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
30. W Miao, Z Luo, and RN Kitsis Intracoronary adenovirus-mediated Akt gene transfer in hearts limits infarct size following ischemia-reperfusion injury J Mol Cell Cardiol 32 2000 2397 2402
31. MM Mocanu, RM Bell, and DM Yellon PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning J Mol Cell Cardiol 34 2002 661 668
32. CE Murry, RB Jennings, and KA Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
33. LA Nikolaidis, S Mankad, and GG Sokos Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965
34. F Okamoto, BS Allen, and GD Buckberg Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion J Thorac Cardiovasc Surg 92 1986 613 620
35. O Oldenburg, Q Qin, and T Krieg Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection Am J Physiol 286 2004 H468 H476
36. S Philipp, JM Downey, and MV Cohen Postconditioning must be initiated in less than 1 minute following reperfusion and is dependent on adenosine receptors and PI3-kinase Circulation 100 2004 804
37. L Samavati, MM Monick, and S Sanlioglu Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism Am J Physiol 283 2002 C273 C281
38. D Schulman, DS Latchman, and DM Yellon Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway Am J Physiol 283 2002 H1481 H1488
39. N Solenkova, MV Cohen, and JM Downey PI3 kinase supports the preconditioned heart through a critical convalescent period JMCC 2005 (submitted)
40. H Tong, W Chen, and C Steenbergen Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C Circ Res 87 2000 309 315
41. H Tong, K Imahashi, and C Steenbergen Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotective Circ Res 90 2002 377 379
42. A Tsang, DJ Hausenloy, and MM Mocanu Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway Circ Res 95 2004 230 232
43. F Tsuruta, N Masuyama, and Y Gotoh The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria J Biol Chem 277 2002 14040 14047
44. XM Yang, T Krieg, and L Cui NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO J Mol Cell Cardiol 36 2004 411 421
45. XM Yang, JB Proctor, and L Cui Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways J Am Coll Cardiol 44 2004 1103 1110
46. DM Yellon, and GF Baxter Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9 1999 245 249
47. ZQ Zhao, JS Corvera, and ME Halkos Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol 285 2003 H579 H588